Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

Substituted mescaline analogue

From Wikipedia, the free encyclopedia
Class of chemical compounds
Mescaline.

Asubstituted mescaline analogue, also known as ascaline and typically but not always a4-substituted 3,5-dimethoxyphenethylamine, is ananalogue of thephenethylamineserotonergic psychedelicmescaline (3,4,5-trimethoxyphenethylamine).[1][2][3][4][5][6][7]

Other related compounds include the2C (4-substituted 2,5-dimethoxyphenethylamine) andDOx (4-substituted 2,5-dimethoxyamphetamine)compounds as well as3,4,5-trimethoxyamphetamine (TMA) and other4-substituted 3,5-dimethoxyamphetamines (3C drugs).[1][2][3][4] They are also mescaline analogues, but the 2C and DOx drugs have a third methoxy group in the 2 position instead of the 3 position while TMA is anamphetamine rather than a phenethylamine.[1][2][3][4]

Thepharmacology of mescaline analogues has been studied.[8][9][10] Mescaline analogues, or 4-substituted 3,5-dimethoxyphenethylamines specifically, tend to be much lesspotent than the 2C and DOx drugs.[1][3][2] This relates to the fact that the 2,4,5-substitution pattern tends to be optimal in terms ofreceptor affinity and potency.[1][11] However, mescaline analogues are frequently much more potent than mescaline.[1][3]

Substituted mescaline analogues have been extensively characterized byAlexander Shulgin and described in his books such asPiHKAL (Phenethylamines I Have Known and Loved)[6] andThe Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds[7] as well as in hisliterature reviews.[1][3][4][5] They have also been studied byDavid E. Nichols[12][13][14] andDaniel Trachsel,[15][8][10] among other researchers.

Use and effects

[edit]
Doses and durations of scalines
CompoundChemical nameDoseDuration
β,β-Dideuteromescaline (β-D)3,4,5-Trimethoxy-β,β-dideuterophenethylamine200–400 mg12 hours
4-Desoxymescaline (DESOXY)4-Methyl-3,5-dimethoxyphenethylamine40–120 mg6–8 hours
4-O-Desmethylmescaline (DESMETHYL)4-Hydroxy-3,5-dimethoxyphenethylamineUnknownUnknown
4-Trideuteromescaline (4-D)4-Trideuteromethoxy-3,5-dimethoxyphenethylamine200–400 mg12 hours
Allylescaline (AL)4-Allyloxy-3,5-dimethoxyphenethylamine20–35 mg8–12 hours
Asymbescaline (ASB)3,4-Diethoxy-5-methoxyphenethylamine200–280 mg10–15 hours
Benzscaline (BZ)4-Benzyloxy-3,5-dimethoxyphenethylamineUnknownUnknown
Biscaline (BI)4-Phenyl-3,5-dimethoxyphenethylamineUnknownUnknown
Buscaline (B)4-Butoxy-3,5-dimethoxyphenethylamine>150 mgSeveral hours
Cyclopropylmescaline (CPM)4-Cyclopropylmethoxy-3,5-dimethoxyphenethylamine60–80 mg12–18 hours
Cycloproscaline (CP)4-Cyclopropoxy-3,5-dimethoxyphenethylamine≥60 mg≥6 hours
Difluoroescaline (DFE)4-(2,2-Difluoroethoxy)-3,5-dimethoxyphenethylamine40–80 mg6–12 hours
Difluoroisoproscaline (DFIP)4-(1,3-Difluoropropoxy)-3,5-dimethoxyphenethylamineUnknownUnknown
Difluoromescaline (DFM)4-Difluoromethoxy-3,5-dimethoxyphenethylamine50–100 mg12–18 hours
Escaline (E)4-Ethoxy-3,5-dimethoxyphenethylamine40–60 mg8–12 hours
Fluoroescaline (FE)4-(2-Fluoroethoxy)-3,5-dimethoxyphenethylamine≥75 mg~6 hours
Fluoroisoproscaline (FIP)4-(1-Fluoroisopropoxy)-3,5-dimethoxyphenethylamineUnknownUnknown
Fluoromescaline (FM)4-Fluoromethoxy-3,5-dimethoxyphenethylamineUnknownUnknown
Fluoroproscaline (FP)4-(3-Fluoropropoxy)-3,5-dimethoxyphenethylamine60–150 mg3–5 hours
Isobuscaline (IB)4-Isobutoxy-3,5-dimethoxyphenethylamine60–100 mg10–14 hours
Isomescaline (IM)2,3,4-Trimethoxyphenethylamine>400 mgUnknown
Isoproscaline (IP)4-Isopropoxy-3,5-dimethoxyphenethylamine40–80 mg10–16 hours
Mescaline (M)3,4,5-Trimethoxyphenethylamine200–400 (50–800) mg10–12 (6–14) hours
Metadifluoromescaline (MDFM)3-(Difluoromethoxy)-4,5-dimethoxyphenylethylamine≥85 mg~8 hours
Metatrifluoromescaline (MTFM)3,4-Dimethoxy-5-(trifluoroisopropoxy)phenethylamineUnknownUnknown
Metaescaline (ME)3-Ethoxy-4,5-dimethoxyphenethylamine200–350 mg8–12 hours
Metaproscaline (MP)3,4-Dimethoxy-5-propoxyphenethylamine>240 mgUnknown
Methallylescaline (MAL)4-Methallyloxy-3,5-dimethoxyphenethylamine40–65 mg12–16 hours
Phenescaline (PE)4-Phenethyloxy-3,5-dimethoxyphenethylamine>150 mgUnknown
Phescaline (PH)4-Phenoxy-3,5-dimethoxyphenethylamineUnknownUnknown
Propynylmescaline4-Propynyloxy-3,5-dimethoxyphenethylamine≥80 mg8–12 hours
Proscaline (P)4-Propoxy-3,5-dimethoxyphenethylamine30–60 mg8–12 hours
sec-Buscaline (SBU)4-sec-Butoxy-3,5-dimethoxyphenethylamineUnknownUnknown
Symbescaline (SB)4-Methoxy-3,5-diethoxyphenethylamine>240 mgUnknown
tert-Buscaline (TBU)4-tert-Butoxy-3,5-dimethoxyphenethylamineUnknownUnknown
Thioasymbescaline (TASB)3-Ethoxy-4-ethylthio-5-methoxyphenethylamine60–100 mg10–15 hours
Thiobuscaline (TB)4-Butylthio-3,5-dimethoxyphenethylamine60–120 mg~8 hours
Thioescaline (TE)4-Ethylthio-3,5-dimethoxyphenethylamine20–30 mg9–12 hours
Thioisomescaline (TIM)2,3-Dimethoxy-4-methylthiophenethylamine>240 mgUnknown
Thiomescaline (TM)4-Methylthio-3,5-dimethoxyphenethylamine20–40 mg10–15 hours
Thiometaescaline (TME)3-Ethoxy-4-methylthio-5-methoxyphenethylamine60–100 mg10–15 hours
Thioproscaline (TP)4-Propylthio-3,5-dimethoxyphenethylamine20–25 mg10–15 hours
Thiosymbescaline (TSB)4-Methylthio-3,5-diethoxyphenethylamine>240 mgUnknown
Thiotrescaline (T-TRIS)4-Ethylthio-3,5-diethoxyphenethylamine>200 mgUnknown
Trescaline (TRIS)3,4,5-Triethoxyphenethylamine>240 mgUnknown
Trifluoroescaline (TFE)4-(2,2,2-Trifluoroethoxy)-3,5-dimethoxyphenethylamine35–65 mg12–18 hours
Trifluoroisoproscaline (TFIP)4-(1,1,1-Trifluoroisopropoxy)-3,5-dimethoxyphenethylamineUnknownUnknown
Trifluoromescaline (TFM)4-(Trifluoromethoxy)-3,5-dimethoxyphenethylamine15–40 mg14–24 hours
Trifluoroproscaline (TFP)4-(3,3,3-Trifluoropropoxy)-3,5-dimethoxyphenethylamine≥60 mgUnknown
Viscaline (V)4-Vinyl-3,5-dimethoxyphenethylamineUnknownUnknown
Refs:[1][3][16][7][17][18][15][19][8]

Interactions

[edit]
See also:Psychedelic drug § Interactions, andTrip killer § Serotonergic psychedelic antidotes

List of substituted mescaline analogues

[edit]

4-Substituted

[edit]

3- or 5-Extended

[edit]

3- or 5-Replaced

[edit]

2- or 6-Substituted

[edit]

N-Substituted

[edit]

α- or β-substituted

[edit]
See also:3C (psychedelics)

Other compounds

[edit]

See also

[edit]

References

[edit]
  1. ^abcdefghShulgin AT (2003)."Basic Pharmacology and Effects". In Laing RR (ed.).Hallucinogens: A Forensic Drug Handbook. Forensic Drug Handbook Series. Elsevier Science. pp. 67–137.ISBN 978-0-12-433951-4. Retrieved1 February 2025.
  2. ^abcdBraun U, Braun G, Jacob P, Nichols DE, Shulgin AT (1978)."Mescaline analogs: substitutions at the 4-position"(PDF).NIDA Res Monogr (22):27–37.PMID 101882. Archived fromthe original(PDF) on August 5, 2023.
  3. ^abcdefgJacob P, Shulgin AT (1994)."Structure-activity relationships of the classic hallucinogens and their analogs"(PDF).NIDA Res Monogr.146:74–91.PMID 8742795. Archived fromthe original(PDF) on August 5, 2023.
  4. ^abcdShulgin AT (1978)."Psychotomimetic Drugs: Structure-Activity Relationships". In Iversen LL, Iversen SD, Snyder SH (eds.).Stimulants. Boston, MA: Springer US. pp. 243–333.doi:10.1007/978-1-4757-0510-2_6.ISBN 978-1-4757-0512-6.
  5. ^abShulgin AT (March 1973)."Mescaline: the chemistry and pharmacology of its analogs".Lloydia.36 (1):46–58.PMID 4576313.
  6. ^abAlexander T. Shulgin;Ann Shulgin (1991).PiHKAL: A Chemical Love Story (1st ed.). Berkeley, CA: Transform Press.ISBN 978-0-9630096-0-9.OCLC 25627628.
  7. ^abcShulgin A, Manning T, Daley PF (2011).The Shulgin Index, Volume One: Psychedelic Phenethylamines and Related Compounds. Vol. 1. Berkeley, CA: Transform Press.ISBN 978-0-9630096-3-0.OCLC 709667010.
  8. ^abcKolaczynska KE, Luethi D, Trachsel D, Hoener MC, Liechti ME (2021)."Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines".Front Pharmacol.12 794254.doi:10.3389/fphar.2021.794254.PMC 8865417.PMID 35222010.
  9. ^Halberstadt AL, Chatha M, Chapman SJ, Brandt SD (March 2019)."Comparison of the behavioral effects of mescaline analogs using the head twitch response in mice".J Psychopharmacol.33 (3):406–414.doi:10.1177/0269881119826610.PMC 6848748.PMID 30789291.
  10. ^abStoeckmann OV, Trachsel D, Liechti ME, Rudin D (21 May 2024)."Supplementum 276: Abstracts of the 8th Annual Spring Congress of the Swiss Society of General Internal Medicine: P181. New Mescaline Derivatives: Profiling of Scalines' Potency and Affinity on Different Serotonin Receptor Subtypes".Swiss Medical Weekly.154 (5): 138S.doi:10.57187/s.3896.ISSN 1424-3997.
  11. ^Dowd CS, Herrick-Davis K, Egan C, DuPre A, Smith C, Teitler M, Glennon RA (August 2000)."1-[4-(3-Phenylalkyl)phenyl]-2-aminopropanes as 5-HT(2A) partial agonists".Journal of Medicinal Chemistry.43 (16):3074–3084.doi:10.1021/jm9906062.PMID 10956215.
  12. ^Nichols DE, Dyer DC (February 1977). "Lipophilicity and serotonin agonist activity in a series of 4-substituted mescaline analogues".J Med Chem.20 (2):299–301.doi:10.1021/jm00212a022.PMID 836502.
  13. ^Monte AP, Waldman SR, Marona-Lewicka D, Wainscott DB, Nelson DL, Sanders-Bush E, Nichols DE (September 1997). "Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives".J Med Chem.40 (19):2997–3008.doi:10.1021/jm970219x.PMID 9301661.
  14. ^McLean TH, Chambers JJ, Parrish JC, Braden MR, Marona-Lewicka D, Kurrasch-Orbaugh D, Nichols DE (July 2006). "C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor".J Med Chem.49 (14):4269–4274.doi:10.1021/jm060272y.PMID 16821786.
  15. ^abTrachsel, D.; Lehmann, D.; Enzensperger, C. (2013).Phenethylamine: von der Struktur zur Funktion [Phenethylamines: From Structure to Function]. Nachtschatten-Science (in German) (1 ed.). Solothurn: Nachtschatten-Verlag.ISBN 978-3-03788-700-4.OCLC 858805226. Retrieved31 January 2025.
  16. ^Shulgin, Alexander;Shulgin, Ann (September 1991).PiHKAL: A Chemical Love Story.Berkeley, California:Transform Press.ISBN 0-9630096-0-5.OCLC 25627628.
  17. ^Halberstadt, Adam L.; Chatha, Muhammad; Klein, Adam K.; Wallach, Jason; Brandt, Simon D. (May 2020)."Correlation between the potency of hallucinogens in the mouse head-twitch response assay and their behavioral and subjective effects in other species"(PDF).Neuropharmacology.167 107933.doi:10.1016/j.neuropharm.2019.107933.PMC 9191653.PMID 31917152.Table 4 Human potency data for selected hallucinogens. [...]
  18. ^Trachsel D (2012)."Fluorine in psychedelic phenethylamines".Drug Test Anal.4 (7–8):577–590.doi:10.1002/dta.413.PMID 22374819.
  19. ^Luethi D, Liechti ME (October 2018). "Monoamine Transporter and Receptor Interaction Profiles in Vitro Predict Reported Human Doses of Novel Psychoactive Stimulants and Psychedelics".Int J Neuropsychopharmacol.21 (10):926–931.doi:10.1093/ijnp/pyy047.PMID 29850881.
  20. ^"PiHKAL·info".2-Chloromescaline. 1 April 2025. Retrieved29 May 2025.
  21. ^"PiHKAL·info".Dibromomescaline. 1 April 2025. Retrieved29 May 2025.
  22. ^"PiHKAL·info".2,6-Dichloromescaline. 1 April 2025. Retrieved29 May 2025.

External links

[edit]


Tryptamines
No ring subs.
4-Hydroxytryptamines
5-Hydroxytryptamines
5-Methoxytryptamines
Other ring subs.
α-Alkyltryptamines
Others
Cyclized
Bioisosteres
Phenethylamines
Scalines
2C-x
3C-x
DOx
4C-x
Ψ-PEA
MDxx
FLY
25x-NB (NBOMes)
Others
Cyclized
Lysergamides
  • Bioisosteres:JRT
Others
Natural sources
Phenethylamines
Amphetamines
Phentermines
Cathinones
Phenylisobutylamines
(and further-extended)
Catecholamines
(and close relatives)
Cyclized
phenethylamines
Phenylalkylpyrrolidines
2-Benzylpiperidines
(phenidates)
Phenylmorpholines
(phenmetrazines)
Phenyloxazolamines
(aminorexes)
Isoquinolines and
tetrahydroisoquinolines
2-Aminoindanes
2-Aminotetralins
Others / unsorted
Related compounds
Stimulants
Depressants
Hallucinogens
Entactogens
Psychiatric drugs
Others
Retrieved from "https://en.wikipedia.org/w/index.php?title=Substituted_mescaline_analogue&oldid=1317257546"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp